Open, Randomized Study to Compare the Immunogenicity and Reactogenicity of an Influenza Split Vaccine with an MF59-Adjuvanted Subunit Vaccine and a Virosome-Based Subunit Vaccine in Elderly

被引：0
|
作者：
B. R. Ruf
K. Colberg
M. Frick
A. Preusche
机构：
[1] Klinikum Sankt Georg Leipzig,
[2] 2nd Dept. of Internal Medicine,undefined
[3] Division of Infectious Diseases and Tropical Medicine,undefined
[4] Medical Practice,undefined
[5] Medical Practice,undefined
[6] Medical Practice,undefined
来源：
Infection | 2004年 / 32卷
关键词：
Adverse Event; Influenza; Multicenter Study; Antibody Titer; Randomize Study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：191 / 198
页数：7
相关论文
共 50 条
  • [1] Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly
    Ruf, BR
    Colberg, K
    Frick, M
    Preusche, A
    INFECTION, 2004, 32 (04) : 191 - 198
  • [2] Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
    Gasparini, R
    Pozzi, T
    Montomoli, E
    Fragapane, E
    Senatore, F
    Minutello, M
    Podda, A
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2001, 17 (02) : 135 - 140
  • [3] Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects
    R. Gasparini
    T. pozzi
    E. Montomoli
    E. Fragapane
    F. Senatore
    M. Minutello
    A. Podda
    European Journal of Epidemiology, 2001, 17 : 135 - 140
  • [4] Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
    De Donato, S
    Granoff, D
    Minutello, M
    Lecchi, G
    Faccini, M
    Agnello, M
    Senatore, F
    Verweij, P
    Fritzell, B
    Podda, A
    VACCINE, 1999, 17 (23-24) : 3094 - 3101
  • [5] Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects
    Squarcione, S
    Sgricia, S
    Biasio, LR
    Perinetti, E
    VACCINE, 2003, 21 (11-12) : 1268 - 1274
  • [6] Increased immunogenicity with an MF59-adjuvanted influenza vaccine (FLUAD®) compared with a conventional subunit vaccine (Agrippal®) in renal transplant recipients
    Pollok, M
    Geiger, H
    Floege, J
    Paschke, R
    Abendroth, D
    Blenzle, U
    Ypma, E
    Banzhoff, A
    OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 : 453 - 456
  • [7] Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
    Li R.
    Fang H.
    Li Y.
    Liu Y.
    Pellegrini M.
    Podda A.
    Immunity & Ageing, 5 (1)
  • [8] Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern Italy
    Villa, Marco
    Black, Steven
    Groth, Nicola
    Rothman, Kenneth J.
    Apolone, Giovanni
    Weiss, Noel S.
    Aquino, Ivana
    Boldori, Liana
    Caramaschi, Fausta
    Gattinoni, Antonio
    Malchiodi, Giancarlo
    Crucitti, Antonio
    Della Cioppa, Giovanni
    Scarpini, Elio
    Mavilio, Domenico
    Mannino, Salvatore
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (07) : 1139 - 1145
  • [9] Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults
    Frey, S
    Poland, G
    Percell, S
    Podda, A
    VACCINE, 2003, 21 (27-30) : 4234 - 4237
  • [10] MF59™-adjuvanted subunit influenza vaccine:: an improved interpandemic influenza vaccine for vulnerable populations
    Barbera, Joan Puig
    Vidal, David Gonzalez
    EXPERT REVIEW OF VACCINES, 2007, 6 (05) : 659 - 665
12345